REGULUS THERAPEUTICS INC's ticker is RGLS and the CUSIP is 75915K200. A total of 45 filers reported holding REGULUS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $664,000 | -5.7% | 2,233,031 | -0.0% | 0.00% | 0.0% |
| Q4 2021 | $704,000 | -54.2% | 2,233,544 | +0.3% | 0.00% | -50.0% |
| Q3 2021 | $1,538,000 | -15.5% | 2,227,212 | -0.5% | 0.00% | 0.0% |
| Q2 2021 | $1,820,000 | -47.6% | 2,237,942 | +0.5% | 0.00% | -50.0% |
| Q1 2021 | $3,474,000 | +414.7% | 2,227,199 | +345.4% | 0.00% | +300.0% |
| Q4 2020 | $675,000 | +33650.0% | 499,989 | +8482.0% | 0.00% | – |
| Q1 2020 | $2,000 | 0.0% | 5,826 | +94.7% | 0.00% | – |
| Q3 2019 | $2,000 | – | 2,993 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 1,450,777 | $1,180,000 | 0.81% |
| Endurant Capital Management LP | 2,607,674 | $2,120,000 | 0.58% |
| Sarissa Capital Management LP | 1,851,851 | $1,506,000 | 0.12% |
| Ikarian Capital, LLC | 1,245,989 | $1,014,000 | 0.08% |
| NEA Management Company, LLC | 6,451,056 | $5,225,000 | 0.07% |
| Focused Wealth Management, Inc | 200,000 | $163,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 206,265 | $168,000 | 0.02% |
| GYL FINANCIAL SYNERGIES, LLC | 41,000 | $33,000 | 0.02% |
| Virtu Financial LLC | 79,193 | $64,000 | 0.01% |
| Pinz Capital Management, LP | 22,300 | $18,000 | 0.01% |